Trial intelligence / Profile preview

Lamictal in post-herpetic neuralgia

NCT00295776Phase 3Terminated

Sponsor
George Washington University
Start
Feb 2005
Primary completion
Dec 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of lamotrigine in postherpetic neuralgia (PHN), sponsored by George Washington University. Started Feb 2005; status: terminated.

02

Drugs

lamotrigine
03

Conditions

postherpetic neuralgia (PHN)

Beyond the preview

Go deeper on NCT00295776.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00295776.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call